Interleukin 6 plasma levels are associated with progression of coronary plaques.
Jordan M KraaijenhofNick S NurmohamedEvangelos TzolosMohammed Nooruddin MeahJolien GeersYannick KaiserJeffrey KroonG Kees HovinghErik S G StroesMarc R DweckPublished in: Open heart (2024)
Plasma IL-6 levels are significantly associated with increased total and noncalcified short-term plaque progression in patients with stable coronary artery disease. This supports the potential of IL-6 as a target for reducing plaque progression and cardiovascular risk.